Becton Dickinson Price to Sales Ratio 2010-2024 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of April 25, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Becton Dickinson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-04-25 |
205.08 |
|
2.89 |
| 2024-12-31 |
225.84 |
$71.05 |
3.18 |
| 2024-09-30 |
238.87 |
$69.40 |
3.44 |
| 2024-06-30 |
230.61 |
$68.36 |
3.37 |
| 2024-03-31 |
243.20 |
$68.11 |
3.57 |
| 2023-12-31 |
238.68 |
$67.61 |
3.53 |
| 2023-09-30 |
252.04 |
$67.53 |
3.73 |
| 2023-06-30 |
256.50 |
$66.46 |
3.86 |
| 2023-03-31 |
239.63 |
$65.67 |
3.65 |
| 2022-12-31 |
245.22 |
$65.33 |
3.75 |
| 2022-09-30 |
214.08 |
$65.71 |
3.26 |
| 2022-06-30 |
236.06 |
$63.87 |
3.70 |
| 2022-03-31 |
247.65 |
$63.50 |
3.90 |
| 2021-12-31 |
233.36 |
$63.68 |
3.66 |
| 2021-09-30 |
227.30 |
$65.36 |
3.48 |
| 2021-06-30 |
224.15 |
$63.88 |
3.51 |
| 2021-03-31 |
223.34 |
$61.62 |
3.62 |
| 2020-12-31 |
229.05 |
$60.36 |
3.79 |
| 2020-09-30 |
212.26 |
$57.60 |
3.69 |
| 2020-06-30 |
217.54 |
$61.04 |
3.56 |
| 2020-03-31 |
208.22 |
$63.37 |
3.29 |
| 2019-12-31 |
245.65 |
$63.45 |
3.87 |
| 2019-09-30 |
227.78 |
$63.25 |
3.60 |
| 2019-06-30 |
226.25 |
$63.21 |
3.58 |
| 2019-03-31 |
223.48 |
$62.97 |
3.55 |
| 2018-12-31 |
201.01 |
$63.22 |
3.18 |
| 2018-09-30 |
232.10 |
$61.44 |
3.78 |
| 2018-06-30 |
212.42 |
$58.96 |
3.60 |
| 2018-03-31 |
191.52 |
$57.09 |
3.35 |
| 2017-12-31 |
188.54 |
$54.93 |
3.43 |
| 2017-09-30 |
172.00 |
$54.96 |
3.13 |
| 2017-06-30 |
170.64 |
$55.65 |
3.07 |
| 2017-03-31 |
159.82 |
$56.62 |
2.82 |
| 2016-12-31 |
143.66 |
$57.15 |
2.51 |
| 2016-09-30 |
155.27 |
$57.54 |
2.70 |
| 2016-06-30 |
145.97 |
$57.43 |
2.54 |
| 2016-03-31 |
130.17 |
$57.23 |
2.27 |
| 2015-12-31 |
131.53 |
$53.33 |
2.47 |
| 2015-09-30 |
112.75 |
$49.93 |
2.26 |
| 2015-06-30 |
119.86 |
$46.32 |
2.59 |
| 2015-03-31 |
120.98 |
$42.76 |
2.83 |
| 2014-12-31 |
116.78 |
$42.99 |
2.72 |
| 2014-09-30 |
95.09 |
$42.75 |
2.22 |
| 2014-06-30 |
98.38 |
$42.16 |
2.33 |
| 2014-03-31 |
96.92 |
$41.54 |
2.33 |
| 2013-12-31 |
91.04 |
$41.14 |
2.21 |
| 2013-09-30 |
81.99 |
$40.49 |
2.02 |
| 2013-06-30 |
80.61 |
$39.35 |
2.05 |
| 2013-03-31 |
77.59 |
$38.66 |
2.01 |
| 2012-12-31 |
63.10 |
$37.76 |
1.67 |
| 2012-09-30 |
63.00 |
$36.66 |
1.72 |
| 2012-06-30 |
59.59 |
$35.51 |
1.68 |
| 2012-03-31 |
61.52 |
$34.60 |
1.78 |
| 2011-12-31 |
58.84 |
$33.93 |
1.73 |
| 2011-09-30 |
57.39 |
$33.42 |
1.72 |
| 2011-06-30 |
67.09 |
$31.93 |
2.10 |
| 2011-03-31 |
61.70 |
$30.88 |
2.00 |
| 2010-12-31 |
65.15 |
$29.83 |
2.18 |
| 2010-09-30 |
56.83 |
$29.61 |
1.92 |
| 2010-06-30 |
51.59 |
$29.83 |
1.73 |
| 2010-03-31 |
59.75 |
$29.55 |
2.02 |
| 2009-12-31 |
59.57 |
$29.10 |
2.05 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$57.057B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
